Concurrent protein C deficiency and lupus anticoagulants
β Scribed by Robert L. Harrison; Jack B. Alperin
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 405 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
An inherited deficiency of protein C, a recognized hypercoagulable state, may cause a clinically significant deep venous thrombosis. Only some persons with a deficiency of protein C experience thrombosis, and almost always the thrombotic event occurs in the venous circulation. Warfarinβinduced skin necrosis, a rare event observed in some patients soon after treatment with warfarin is begun, is believed to be another manifestation of this deficiency. We describe a young woman whose basal functional and antigenic levels of protein C were about 45% and who experienced both deep venous thrombosis and warfarinβinduced skin necrosis in a clinically severe course. Evidence for lupus anticoagulants was present, with prolonged activated partial thromboplastin time that was corrected when lysed platelets were added, prolonged Russell's viper venom time, anticardiolipin antibodies, and other laboratory evidence. Lupus anticoagulants are associated also with a significant incidence of thrombosis, including arterial thrombosis, and this patient developed concurrently arterial thrombosis. The combined effects of protein C deficiency and lupus anticoagulants, exacerbated by other potentially thrombogenic conditions, are believed responsible for the severe thrombotic events experienced by this patient. Β© 1992 WileyβLiss, Inc.
π SIMILAR VOLUMES
The role of antibiotic therapy in the prevention of empyema in patients with an isolated chest injury (ISS 9-10): a prospective study.
C2 deficiency (C2d) is the most common hereditary human complement component defect (1). The prevalence of homozygous C2d has been estimated from 1 in 10,000 to 1 in 40,000 people, while heterozygous C2d is found in 1-2% (2,3). The gene(s) coding for the synthesis of this protein are within the majo